Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Jun 25, 2018
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Purchase
Ordinary Shares
2018-06-22$3.73/sh+5,500$20,515→ 5,500 total
4 · Nabriva Therapeutics plc · Filed Jun 25, 2018
Ordinary Shares